Get the Stockscreener App
21.92
0.05%
0.01
Tectonic Therapeutic Inc stock is traded at $21.92, with a volume of 154.68K.
It is up +0.05% in the last 24 hours and up +10.65% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$21.91
Open:
$22.84
24h Volume:
154.68K
Relative Volume:
0.77
Market Cap:
$409.30M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.19%
1M Performance:
+10.65%
6M Performance:
-47.03%
1Y Performance:
+32.85%
1-Day Range:
$21.41
$23.61
1-Week Range:
$20.41
$23.77
52-Week Range:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
21.92 | 431.71M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
What analysts say about Tectonic Therapeutic Inc. stockMarket-crushing stock picks - jammulinksnews.com
Tectonic Therapeutic (NASDAQ:TECX) Now Covered by Truist Financial - Defense World
Is Tectonic Therapeutic Inc. a good long term investmentTremendous gains - Autocar Professional
Tectonic Therapeutic, Inc. Rings the Closing Bell - Nasdaq
Truist Securities initiates Tectonic Therapeutics stock with Buy rating - Investing.com India
Tectonic Therapeutic Inc. Stock Analysis and ForecastStrong return on assets - PrintWeekIndia
What drives Tectonic Therapeutic Inc. stock priceHigh-return market picks - PrintWeekIndia
What institutions are buying Tectonic Therapeutic Inc. stock nowFree Stock Market Analysis Courses - Newser
What analysts say about Tectonic Therapeutic Inc. stock outlookBreakout Level Watch - Newser
What makes Tectonic Therapeutic Inc. stock price move sharplyLow Risk Consistent Winners - Newser
How Tectonic Therapeutic Inc. stock performs during market volatilityLong Term Secure Gain Stocks - Newser
Why Tectonic Therapeutic Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Russell 2000 Implied Analyst Target Price at $269.34, 20.67% Upside to Current Price of $223.21. - AInvest
Tectonic Therapeutic shares fall 1.44% intraday after filing $400 million mixed shelf. - AInvest
Tectonic Therapeutics: Strategic Capital Allocation Fuels Growth in Untapped GPCR Markets - AInvest
Tectonic Therapeutic Files $400 Million Mixed Shelf - MarketScreener
Clinical-Stage Biotech Tectonic Therapeutic Secures Coveted Russell 3000 Index Position - Stock Titan
Raymond James Resumes Coverage of Tectonic Therapeutic (TECX) With an Outperform Rating - MSN
13 Small Cap Stocks Analysts Are Bullish On - Insider Monkey
Tectonic Therapeutic (NASDAQ:TECX) & Invivyd (NASDAQ:IVVD) Head-To-Head Comparison - Defense World
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated at Raymond James - Defense World
Analysts Set Tectonic Therapeutic (NASDAQ:TECX) PT at $80.50 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Upgraded at Lifesci Capital - Defense World
Lifesci Capital Initiates Coverage on Tectonic Therapeutic (NASDAQ:TECX) - Defense World
tectonic therapeutic holds annual meeting, elects directors By Investing.com - Investing.com India
LifeSci Capital Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation - Nasdaq
Tectonic Therapeutic Holds 2025 Annual Stockholders Meeting - TipRanks
tectonic therapeutic holds annual meeting, elects directors - Investing.com
Ameriprise Financial Inc. Takes $347,000 Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Wall Street Analysts See a 258.52% Upside in Tectonic Therapeutic, Inc. (TECX): Can the Stock Really Move This High? - MSN
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.87%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):